ARKK vs CDTX
ARK Innovation ETF (ARKK) versus Cidara Therapeutics Inc (CDTX) — a side-by-side from cached financials, not a winner call.
ARK Innovation ETF (ARKK) common stock listed on US.
Cidara Therapeutics Inc (CDTX) is a biotechnology company listed on US.
ARKK does not have a complete income-statement cache yet.
Latest reported CDTX revenue for 2024-12-31 was $1.3M. Net income was -$169.8M. Revenue was down 94.5% from 2023-12-31 to 2024-12-31. CDTX currently screens at market cap $6.96B.
ARKK currently screens at market cap $0. CDTX currently screens at market cap $6.96B.
Not investment advice. Open the ARKK and CDTX stock pages for the full models.
Not investment advice.